Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Interim Management Statement

20 May 2011 16:16

RNS Number : 0399H
Maven Income & Growth VCT 4 PLC
20 May 2011
 



 

Maven Income and Growth VCT 4 PLC

 

Interim Management Statement

 

 

1. Net Asset Value

 

·; Ordinary share net asset value (NAV) Total Return of 115.0p per share and net asset value of 98.7p at 31 March 2011.

 

·; S Ordinary share NAV Total Return of 104.95p and NAV of 98.4p at 31 March 2011.

 

The NAVs shown above are unaudited and reflect the closing bid prices of quoted securities at 31 March 2011. Unlisted companies are normally valued on a six-monthly basis and the NAVs include the Directors' valuations of unlisted investments as at 31 December 2011 adjusted for material developments within the portfolios since that date.

 

2. Investments and disposals

 

During the quarter ended 31 March 2011, the Ordinary share portfolio invested £199,610 in private equity investments. During the same period, disposals generated aggregate proceeds of £486,380 against a cost of £372,444.

 

The S share portfolio invested £124,858 in private equity investments during the same period, and generated aggregate disposals proceeds of £145,450 against cost of £102,239.

 

There were no other material transactions during the period under review. 

 

3. Issue of shares

As previously announced, the Company has issued 431,672 Ordinary shares in respect of the Maven Linked VCT Offer 2.

4. Recent developments

Since 31 March 2011, the Ordinary share portfolio has invested £86,000 in Torridon Capital, which supplies legal and financial insurance products and litigation services. The S share portfolio invested £73,000 in the same company.

 

Further disposals generated proceeds of £4,080 for the Ordinary share portfolio against costs of £3,044.

 

The Board is not aware of any other events or transactions that have taken place between 31 March 2011 and the date of publication of this statement and which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

 

20 May 2011

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSURAVRAOAVUAR
Date   Source Headline
11th Nov 20205:01 pmRNSNet Asset Value(s)
2nd Oct 202012:41 pmRNSIssue of Equity
29th Sep 20204:49 pmRNSStatement re Dividend Investment Scheme
1st Sep 20204:35 pmRNSTransaction in Own Shares
28th Aug 20202:38 pmRNSHalf-year Report
26th Aug 20205:26 pmRNSTransaction in Own Shares
20th Aug 202011:38 amRNSStatement re NAV, Interim Dividend and DIS
20th Aug 202011:29 amRNSDirector Declaration
9th Jul 202010:00 amRNSIssue of Equity
8th Jun 20209:36 amRNSAllotment Update
21st May 202012:17 pmRNSResult of AGM
15th May 20204:10 pmRNSNet Asset Value(s)
7th May 20204:35 pmRNSPublication of Suppl.Prospcts
21st Apr 20206:24 pmRNSAnnual Financial Report
8th Apr 20203:56 pmRNSStatement re Offer for Subscription
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:00 pmRNSAllotment Update and Suspension of DIS
20th Mar 20204:57 pmRNSTransaction in Own Shares
28th Feb 20204:56 pmRNSTransaction in Own Shares
24th Feb 20204:35 pmRNSStatement re Net Asset Value and Proposed Dividend
11th Feb 20205:04 pmRNSDirector/PDMR Shareholding
11th Feb 20205:02 pmRNSDirector/PDMR Shareholding
11th Feb 20204:24 pmRNSIssue of Equity
6th Feb 20203:39 pmRNSStatement re Offer for Subscription
18th Dec 20192:14 pmRNSDirectorate Change
18th Dec 20192:09 pmRNSMerger Update: Approval of Scheme
10th Dec 201912:30 pmRNSResult of General Meeting
14th Nov 20196:20 pmRNSStatement re Offer for Subscription
14th Nov 20196:20 pmRNSStatement re Proposed Merger
7th Nov 20192:11 pmRNSNet Asset Value(s)
4th Oct 201911:30 amRNSDirector/PDMR Shareholding
4th Oct 201910:22 amRNSIssue of Equity
1st Oct 201912:34 pmRNSNet Asset Value(s)
20th Sep 201912:44 pmRNSHalf-year Report
19th Sep 20193:46 pmRNSTransaction in Own Shares
17th Sep 20193:00 pmRNSTransaction in Own Shares
28th Aug 20192:59 pmRNSStatement re Possible Merger
27th Aug 20194:38 pmRNSStatement re NAV and Interim Dividend
23rd Aug 20194:23 pmRNSStatement re Intended Joint Offer for Subscription
21st Aug 20194:14 pmRNSStatement re share premium account cancellation
21st May 20194:04 pmRNSTransaction in Own Shares
15th May 20195:02 pmRNSNet Asset Value(s)
15th May 20192:08 pmRNSResult of AGM
5th Apr 20193:25 pmRNSAnnual Financial Report
12th Mar 20192:52 pmRNSTransaction in Own Shares
28th Feb 20194:03 pmRNSNet Asset Value(s)
4th Dec 20184:42 pmRNSTransaction in Own Shares
27th Nov 20183:15 pmRNSTransaction in Own Shares
22nd Nov 20183:14 pmRNSTransaction in Own Shares
19th Nov 201811:45 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.